Tariff Policies Impact Pharmaceutical and Biotechnology Sectors, Affecting Costs, Supply Chains, and Global Trade
Changing tariff policies are influencing pharmaceutical and biotechnology sectors by increasing costs, disrupting supply chains, and altering global trade dynamics. Companies must navigate regulatory challenges and adapt strategies to maintain competitiveness while ensuring continuous innovation and product availability in a volatile trade environment.